Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 493,970 | 478,477 | 464,232 | 469,129 | 445,763 |
| Cost of Goods | 312,501 | 311,083 | 287,385 | 283,804 | 274,411 |
| Gross Profit | 181,469 | 167,394 | 176,847 | 185,325 | 171,352 |
| Operating Expenses | 114,141 | 104,649 | 103,170 | 104,443 | 102,057 |
| Operating Income | 67,829 | 62,828 | 74,062 | 81,686 | 69,706 |
| Interest Expense | 11,191 | 7,724 | 7,667 | 7,403 | 6,983 |
| Other Income | 6,402 | 13,949 | 6,544 | 2,633 | 15,324 |
| Pre-tax Income | 63,040 | 69,053 | 72,939 | 76,916 | 78,047 |
| Income Tax | 9,772 | 98,097 | 19,945 | 22,243 | 31,084 |
| Net Income Continuous | 53,268 | -29,044 | 52,994 | 54,673 | 46,963 |
| Net Income Discontinuous | -23 | -23 | -39 | -71 | -4 |
| Minority Interests | 614 | 782 | 481 | 650 | 181 |
| Net Income | $52,631 | $-29,849 | $52,474 | $53,952 | $46,778 |
| EPS Basic Total Ops | 1.10 | -0.62 | 1.11 | 1.13 | 0.98 |
| EPS Basic Continuous Ops | 1.10 | -0.63 | 1.11 | 1.14 | 0.98 |
| EPS Diluted Total Ops | 1.08 | -0.63 | 1.08 | 1.12 | 0.97 |
| EPS Diluted Continuous Ops | 1.08 | -0.64 | 1.09 | 1.12 | 0.97 |
| EBITDA(a) | $101,039 | $96,312 | $107,527 | $113,485 | $102,117 |